Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Di Rocco

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Hematological Oncology|December 15, 2022
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective studyGiovanni Manfredi Assanto, Alice Di Rocco, Francesco Malfona, et al.
Leukemia & Lymphoma|June 3, 2016
The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective studyPier Luigi Zinzani, Luigi Rigacci, Maria Cristina Cox, et al.
Bone Marrow Transplantation|January 25, 2024
Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphomaChiara De Philippis, Cristina Zucchinetti, Daniele Mannina, et al.
Journal of Clinical Medicine|June 10, 2023
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional StudyGiuseppe Facondo, Mattia Serio, Gianluca Vullo, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphomaVitaliana De Sanctis, Erica Finolezzi, Mattia Falchetto Osti, et al.
La Radiologia Medica|May 5, 2023
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomasFrancesca Maccioni, Giulia Alfieri, Giovanni Manfredi Assanto, et al.
Annals of Hematology|August 31, 2023
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from ItalyMarcella Visentini, Andrea Pica, Giancarlo D'Ippolito, et al.
Leukemia & Lymphoma|September 23, 2014
Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practicePier Luigi Zinzani, Luigi Rigacci, Maria Cristina Cox, et al.
Annals of Hematology|May 15, 2014
Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA studyMathias Witzens-Harig, Robin Foá, Alice Di Rocco, et al.
Frontiers in Oncology|November 22, 2021
CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)Guido Gini, Alice Di Rocco, Luca Nassi, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Hematological Oncology|December 15, 2022
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective studyGiovanni Manfredi Assanto, Alice Di Rocco, Francesco Malfona, et al.
Leukemia & Lymphoma|June 3, 2016
The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective studyPier Luigi Zinzani, Luigi Rigacci, Maria Cristina Cox, et al.
Bone Marrow Transplantation|January 25, 2024
Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphomaChiara De Philippis, Cristina Zucchinetti, Daniele Mannina, et al.
Journal of Clinical Medicine|June 10, 2023
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional StudyGiuseppe Facondo, Mattia Serio, Gianluca Vullo, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphomaVitaliana De Sanctis, Erica Finolezzi, Mattia Falchetto Osti, et al.
La Radiologia Medica|May 5, 2023
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomasFrancesca Maccioni, Giulia Alfieri, Giovanni Manfredi Assanto, et al.
Annals of Hematology|August 31, 2023
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from ItalyMarcella Visentini, Andrea Pica, Giancarlo D'Ippolito, et al.
Leukemia & Lymphoma|September 23, 2014
Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practicePier Luigi Zinzani, Luigi Rigacci, Maria Cristina Cox, et al.
Annals of Hematology|May 15, 2014
Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA studyMathias Witzens-Harig, Robin Foá, Alice Di Rocco, et al.
Frontiers in Oncology|November 22, 2021
CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)Guido Gini, Alice Di Rocco, Luca Nassi, et al.
Pageof 11